-
Signature
-
/s/ Paul Breaux, by Power of Attorney for Daniel J. Gill
-
Issuer symbol
-
CVNA
-
Transactions as of
-
06 Jun 2025
-
Transactions value $
-
$-8,649,336
-
Form type
-
4
-
Filing time
-
09 Jun 2025, 19:17:50 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| GILL DANIEL J. |
Chief Product Officer |
C/O CARVANA CO., 300 E. RIO SALADO PARKWAY, TEMPE |
/s/ Paul Breaux, by Power of Attorney for Daniel J. Gill |
09 Jun 2025 |
0001700538 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CVNA |
Class A Common Stock |
Options Exercise |
$255,778 |
+25,400 |
+12.7% |
$10.07 |
225,156 |
06 Jun 2025 |
Direct |
F1 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$-7,184,430 |
-20,500 |
-9.1% |
$350.46 |
204,656 |
06 Jun 2025 |
Direct |
F1, F2 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$-1,720,684 |
-4,900 |
-2.39% |
$351.16 |
199,756 |
06 Jun 2025 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CVNA |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-25,400 |
-8.97% |
$0.000000 |
257,886 |
06 Jun 2025 |
Class A Common Stock |
25,400 |
$10.07 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: